Image pharmaphorum Editor R&D 12 Questions with Dr Michelle Longmire As the co-founder and chief executive officer of Medable, Dr Michelle Longmire is mission-driven to accelerate the development of new therapies for disease. R&D Inside out – the coming of age of organ-on-a-chip technology Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations. R&D Research & Development 2023 So, what does 2023 have in store for pharma R&D? Digital Tackling ongoing staffing burnout rates through AI-enabled p... The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows. Load more results
R&D 12 Questions with Dr Michelle Longmire As the co-founder and chief executive officer of Medable, Dr Michelle Longmire is mission-driven to accelerate the development of new therapies for disease.
R&D Inside out – the coming of age of organ-on-a-chip technology Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations.
Digital Tackling ongoing staffing burnout rates through AI-enabled p... The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows.
News Madrigal closes on EU approval of first MASH treatment Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a MASH treatment.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
